MJ Fowler - Clinical Diabetes, 2008 - Am Diabetes Assoc The importance of protecting the body from hyperglycemia cannot be overstated;
the direct and indirect effects on the human vascular tree are the major source
of morbidity and mortality in both type 1 and type 2 diabetes. Generally, ... Cited by 14 - Related articles - BL Direct - All 2 versions
- ►uky.edu [PDF] X Tang, G Tang, S Özcan - BBA-Gene Regulatory Mechanisms, 2008 - Elsevier Diabetes is one of the most common chronic diseases in the world. Multiple and
complex factors including various genetic and physiological changes can lead to
type 1 and type 2 diabetes. However, the major mechanisms underlying the ... Cited by 14 - Related articles - All 4 versions
OI Okereke, JH Kang, NR Cook, JM Gaziano, … - Journal of the American Geriatrics Society, 2008 - ccmjournal.org From the * Division of Aging; † Channing Laboratory; ‡ Division of
Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and
Harvard Medical School, Boston, Massachusetts; § Department of ... Cited by 11 - Related articles - BL Direct - All 4 versions
JC Ansquer, C Foucher, P Aubonnet, K Le … - Current pharmaceutical design, 2009 - ingentaconnect.com Abstract: Fibrates are widely prescribed lipid-lowering drug in the treatment of
dyslipidemia. Their main clinical effects, mediated by peroxisome proliferative
activated receptor (PPAR) alpha activation, are a moderate reduction in ... Cited by 7 - Related articles - All 3 versions
- ►ksu.edu.sa [PDF] H Ahmad Khan - Acta Diabetologica, 2007 - Springer Abstract Diabetic patients with accompanied (but often unnoticed) dyslipidemia
are soft targets of cardiovascular deaths. An early intervention to normalize
circulating lip- ids has been shown to reduce cardiovascular complications ... Cited by 4 - Related articles - BL Direct - All 6 versions
CB Giorda, A Avogaro, M Maggini, F Lombardo, … - Diabetes care, 2008 - Am Diabetes Assoc RESULTS—During 4 years of follow-up, in cohort A the age-adjusted incidence of
a recurrent event (per 1,000 person-years) was 72.7 (95% CI 58.3–87.1) in men
and 32.5 (21.2–43.7) in women, whereas in cohort B it was 40.1 ... Cited by 5 - Related articles - All 4 versions
HE Mulnier, HE Seaman, VS Raleigh, SS … - Diabetologia, 2008 - Springer Abstract Aims/hypothesis Our primary aim was to establish reliable and
generalisable estimates of the risk of myocardial infarction (MI) for men and
women with type 2 diabetes in the UK compared with people without diabetes. ... Cited by 2 - Related articles - All 3 versions
G De Berardis, M Sacco, GFM Strippoli, F … - British Medical Journal, 2009 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Objective To evaluate the ... Cited by 1
A Gastaldelli, A Casolaro, D Ciociaro, S … - American Journal of Physiology- Endocrinology And …, 2009 - Am Physiological Soc Pioglitazone has been shown to reduce fasting triglyceride levels. The
mechanisms of this effect have not been fully elucidated, but decreased
lipolysis may contribute to blunt the hypertriglyceridemic response to a ... Cited by 1 - Related articles - All 3 versions
- ►socionet.org EM Pelletier, B Shim, R Ben-Joseph, JJ Caro - Pharmacoeconomics, 2009 - ingentaconnect.com 1 Health Economics and Outcomes Research, IMS Health Incorporated, Watertown,
Massachusetts, USA 2 Health Outcomes, sanofi-aventis, Bridgewater, New Jersey,
USA 3 United BioSource Corp, Concord, Massachusetts, USA Related articles - All 9 versions
